We are live on ! Find out more
HLVX

HilleVax
HLVX

Delisted

HLVX was delisted on the 16th of September, 2025.

Back to rankings

57 hedge funds and large institutions have $254M invested in HilleVax in 2022 Q2 according to their latest regulatory filings, with 57 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

69.47% more ownership

Funds ownership: 0% → 69.47% (+69%)

Holders
57
Holders Change
+57
Holders Change %
–
% of All Funds
0.96%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.05%
New
57
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
FLSM
Frazier Life Sciences Management
California
+$110M
2
DM
Deerfield Management
New York
+$31.1M
3
A
Abingworth
United Kingdom
+$21.8M
4
RCM
RA Capital Management
Massachusetts
+$20.9M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$13.1M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
CSS
51
Cubist Systematic Strategies
Connecticut
$9K +$9.5K +800 New
Barclays
52
Barclays
United Kingdom
$7K +$7.72K +650 New
UBS Group
53
UBS Group
Switzerland
$6K +$6.78K +571 New
Wells Fargo
54
Wells Fargo
California
$2K +$2.32K +195 New
Royal Bank of Canada
55
Royal Bank of Canada
Ontario, Canada
$1K +$867 +73 New
CS
56
Credit Suisse
Switzerland
– +$119 +10 New
Fidelity Investments
57
Fidelity Investments
Massachusetts
– +$178 +15 New
1 2
3

HLVX Hedge Fund Activity: Q2 2022 in Review

57 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in HilleVax (HLVX) for Q2 2022, worth a combined $254M.

Buyers outnumbered sellers: 57 funds opened new HLVX positions and 0 closed out — a net gain of 57 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Frazier Life Sciences Management, opening a new position worth an estimated $110M.

  • 57 institutional investors held HilleVax (HLVX) as of Q2 2022, up from 0 in Q1 2022.
  • Funds reported $254M of HilleVax stock for Q2 2022.
  • 57 funds opened new HilleVax positions in Q2 2022 and 0 closed out, a net change of +57 holders.
  • The largest HilleVax buyer in Q2 2022 was Frazier Life Sciences Management, an estimated $110M added.

Based on aggregated 13F filings for Q2 2022.